
Both are 4-in-1 high-potency healing blends sharing the same three-compound base. The difference is one compound that changes everything. Here is the full breakdown.
Both blends share the same three-compound healing foundation. KLOW adds KPV as a fourth compound, which is the only difference between them. That one addition opens up an entirely different set of applications.
| Feature | GLOW | KLOW |
|---|---|---|
| GHK-Cu (Copper Peptide) | ||
| BPC-157 (Body Protection Compound) | ||
| TB-500 (Thymosin Beta-4) | ||
| KPV (Lys-Pro-Val) | ||
| Skin & Anti-Aging Focus | ||
| Deep Immune Modulation | ||
| GI / IBD Application | ||
| Musculoskeletal Repair | ||
| Protocol Simplicity |
Since both blends share the same base, the comparison comes down to where each one excels and which use cases are unique to KLOW.
| Category | GLOW | KLOW |
|---|---|---|
| Primary Use Case | TieAnti-aging, skin vitality, tissue repair | TieChronic inflammation, immune modulation, GI repair |
| Compound Count | Tie3 (GHK-Cu, BPC-157, TB-500) | Tie4 (GHK-Cu, BPC-157, TB-500, KPV) |
| Skin & Hair Results | WinnerStrong — GHK-Cu is the primary driver | Strong — same GHK-Cu base, KPV adds anti-inflammatory skin support |
| Inflammation Control | Moderate — BPC-157 provides local anti-inflammatory action | WinnerDeep — KPV adds systemic melanocortin-mediated immune suppression |
| GI / Gut Health | Mild — BPC-157 has some GI protective effects | WinnerStrong — KPV specifically targets gut mucosal repair |
| Musculoskeletal Repair | TieStrong — TB-500 + BPC-157 is a proven healing combination | TieStrong — same base, KPV adds reduced inflammatory burden |
| Protocol Complexity | WinnerSimpler — 3 compounds to manage | Slightly more complex — 4 compounds, oral KPV option for GI |
| Research Depth | TieStrong — all 3 compounds have extensive published data | TieStrong — KPV adds well-studied melanocortin pathway evidence |

Both blends follow the same injection protocol. The only practical difference is that KLOW's KPV component can optionally be taken orally for gut-specific applications.
| Protocol Aspect | GLOW | KLOW |
|---|---|---|
| Typical Dose | 250–500 mcg/day | 250–500 mcg/day |
| Injection Frequency | Once daily (subcutaneous) | Once daily (subcutaneous) |
| Cycle Length | 4–8 weeks on, 2–4 weeks off | 4–8 weeks on, 2–4 weeks off |
| Oral Option | Not applicable | KPV can be taken orally for GI-specific use |
| Storage | Refrigerated, protect from light | Refrigerated, protect from light |
| Reconstitution | BAC water, standard protocol | BAC water, standard protocol |
| Best Time to Inject | Morning or post-workout | Morning or post-workout |
Both blends have well-tolerated safety profiles. The main additional consideration with KLOW is KPV's immune-modulating activity, which requires caution if you are on immunosuppressant medication.
| Side Effect | GLOW | KLOW |
|---|---|---|
| Injection Site Redness | Mild, temporary | Mild, temporary |
| Fatigue (initial) | Occasional | Occasional |
| Nausea | Rare | Rare |
| Skin Flushing | Rare | Possible with KPV (melanocortin effect) |
| Immunosuppression Risk | Very low | Low — caution with active infections |
| Interaction with Immunosuppressants | None known | Consult provider — KPV modulates immune pathways |
| GI Discomfort | Rare | Rare (KPV typically improves GI symptoms) |
Read the full peptide profiles for GLOW and KLOW, including complete dosing protocols, reconstitution guides, and FAQ sections.